VanEck Biotech ETF (NASDAQ:BBH) Short Interest Up 75.0% in September

VanEck Biotech ETF (NASDAQ:BBH) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 700 shares, an increase of 75.0% from the September 15th total of 400 shares. Based on an average daily volume of 5,200 shares, the short-interest ratio is presently 0.1 days.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Commonwealth Equity Services LLC increased its position in shares of VanEck Biotech ETF by 1.1% in the 1st quarter. Commonwealth Equity Services LLC now owns 30,426 shares of the company’s stock valued at $5,061,000 after acquiring an additional 340 shares during the period. Northwestern Mutual Wealth Management Co. increased its holdings in VanEck Biotech ETF by 5.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 24,324 shares of the company’s stock valued at $4,096,000 after purchasing an additional 1,334 shares during the last quarter. Valley Wealth Managers Inc. boosted its stake in shares of VanEck Biotech ETF by 12.5% in the first quarter. Valley Wealth Managers Inc. now owns 19,308 shares of the company’s stock valued at $3,212,000 after purchasing an additional 2,146 shares during the period. Atlas Capital Advisors LLC acquired a new position in VanEck Biotech ETF during the 2nd quarter worth $960,000. Finally, Truist Financial Corp grew its holdings in VanEck Biotech ETF by 3.8% during the 2nd quarter. Truist Financial Corp now owns 2,703 shares of the company’s stock worth $455,000 after acquiring an additional 100 shares in the last quarter. 32.05% of the stock is currently owned by institutional investors.

VanEck Biotech ETF Trading Up 1.3 %

BBH stock traded up $2.37 during midday trading on Friday, reaching $177.93. 2,326 shares of the company’s stock traded hands, compared to its average volume of 6,921. The company has a 50-day moving average price of $178.10 and a two-hundred day moving average price of $170.73. VanEck Biotech ETF has a 52 week low of $142.51 and a 52 week high of $183.64.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.